Brain Tumors in Adults

We take on the most difficult to treat brain tumors, including glioblastomas, gliomas, astrocytomas, meningiomas, and metastatic brain tumors. We’re nationally known for providing innovative precision molecular diagnoses for brain tumors, and for our expertise in neurosurgery, neuro-oncology, and Gamma Knife®, a precisely targeted radiation treatment for complex brain tumors. We believe that, in some cases, the standard of care may be outdated and might not be the best treatment for you. That’s why we base your care plan on the tumor’s precise molecular makeup, delivering truly individualized care with compassion. We also design cutting-edge clinical trials to find promising new treatments.

Clinical Trials and Research Studies

Phase 1

A Phase I/II Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma

Learn More

Phase 2

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)

Learn More

Phase 2

A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 mutant Advanced Solid Tumors

Learn More

Phase 3

A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727 IND# 77782) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1(NF1)

Learn More